Medicinova Stock Return On Asset

MNOV Stock  USD 1.90  0.21  12.43%   
MediciNova fundamentals help investors to digest information that contributes to MediciNova's financial success or failures. It also enables traders to predict the movement of MediciNova Stock. The fundamental analysis module provides a way to measure MediciNova's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MediciNova stock.
Return On Assets is likely to drop to -0.14 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MediciNova Company Return On Asset Analysis

MediciNova's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current MediciNova Return On Asset

    
  -0.0951  
Most of MediciNova's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MediciNova is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

MediciNova Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for MediciNova is extremely important. It helps to project a fair market value of MediciNova Stock properly, considering its historical fundamentals such as Return On Asset. Since MediciNova's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MediciNova's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MediciNova's interrelated accounts and indicators.
1.0-0.750.0-0.860.170.240.990.9-0.510.030.33-0.27-0.470.960.88-0.82-0.20.930.930.56
1.0-0.71-0.05-0.850.160.261.00.9-0.450.040.29-0.27-0.420.970.89-0.8-0.140.930.930.54
-0.75-0.71-0.490.56-0.27-0.19-0.65-0.860.89-0.13-0.54-0.030.91-0.61-0.680.610.29-0.57-0.56-0.51
0.0-0.05-0.490.110.16-0.1-0.090.13-0.770.250.070.61-0.76-0.19-0.170.230.15-0.23-0.23-0.21
-0.86-0.850.560.11-0.280.12-0.86-0.730.30.06-0.390.290.28-0.86-0.790.740.32-0.84-0.85-0.57
0.170.16-0.270.16-0.28-0.110.150.29-0.2-0.080.4-0.04-0.190.190.3-0.39-0.280.070.060.27
0.240.26-0.19-0.10.12-0.110.260.27-0.07-0.3-0.09-0.39-0.040.240.29-0.370.10.230.220.25
0.991.0-0.65-0.09-0.860.150.260.87-0.390.020.25-0.29-0.360.980.88-0.79-0.110.930.930.53
0.90.9-0.860.13-0.730.290.270.87-0.610.110.49-0.21-0.620.880.92-0.77-0.180.730.720.63
-0.51-0.450.89-0.770.3-0.2-0.07-0.39-0.61-0.22-0.41-0.30.96-0.32-0.370.310.17-0.3-0.3-0.25
0.030.04-0.130.250.06-0.08-0.30.020.11-0.22-0.310.76-0.27-0.06-0.160.390.39-0.19-0.16-0.55
0.330.29-0.540.07-0.390.4-0.090.250.49-0.41-0.31-0.41-0.390.370.6-0.58-0.820.320.30.83
-0.27-0.27-0.030.610.29-0.04-0.39-0.29-0.21-0.30.76-0.41-0.35-0.4-0.510.680.52-0.46-0.43-0.77
-0.47-0.420.91-0.760.28-0.19-0.04-0.36-0.620.96-0.27-0.39-0.35-0.29-0.350.270.12-0.25-0.25-0.21
0.960.97-0.61-0.19-0.860.190.240.980.88-0.32-0.060.37-0.4-0.290.94-0.84-0.190.910.920.65
0.880.89-0.68-0.17-0.790.30.290.880.92-0.37-0.160.6-0.51-0.350.94-0.9-0.370.820.820.83
-0.82-0.80.610.230.74-0.39-0.37-0.79-0.770.310.39-0.580.680.27-0.84-0.90.53-0.84-0.82-0.85
-0.2-0.140.290.150.32-0.280.1-0.11-0.180.170.39-0.820.520.12-0.19-0.370.53-0.33-0.31-0.68
0.930.93-0.57-0.23-0.840.070.230.930.73-0.3-0.190.32-0.46-0.250.910.82-0.84-0.331.00.61
0.930.93-0.56-0.23-0.850.060.220.930.72-0.3-0.160.3-0.43-0.250.920.82-0.82-0.311.00.58
0.560.54-0.51-0.21-0.570.270.250.530.63-0.25-0.550.83-0.77-0.210.650.83-0.85-0.680.610.58
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

MediciNova Total Assets

Total Assets

62.3 Million

At this time, MediciNova's Total Assets are fairly stable compared to the past year.
Based on the latest financial disclosure, MediciNova has a Return On Asset of -0.0951. This is 98.91% lower than that of the Biotechnology sector and 99.6% lower than that of the Health Care industry. The return on asset for all United States stocks is 32.07% lower than that of the firm.

MediciNova Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MediciNova's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MediciNova could also be used in its relative valuation, which is a method of valuing MediciNova by comparing valuation metrics of similar companies.
MediciNova is currently under evaluation in return on asset category among its peers.

MediciNova Current Valuation Drivers

We derive many important indicators used in calculating different scores of MediciNova from analyzing MediciNova's financial statements. These drivers represent accounts that assess MediciNova's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of MediciNova's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap290.9M233.6M130.2M100.5M90.5M99.2M
Enterprise Value227.5M173.8M58.9M82.2M74.0M82.8M

MediciNova Fundamentals

About MediciNova Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze MediciNova's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MediciNova using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MediciNova based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.